3D Software Helps Cardiologists Plan Ahead for TAVR Complications

Why It Matters

Personalized, data‑driven planning reduces catastrophic TAVR complications and unnecessary interventions, improving outcomes and cost efficiency as the procedure expands to broader patient groups.

Key Takeaways

• AI‑3D modeling predicts rare TAVR complications.
• Valve selection now individualized per patient anatomy.
• Leaflet‑modification procedures reduced >70% in 2023.
• Multiple valve platforms evaluated virtually before implantation.
• Predictive metrics improve coronary occlusion risk assessment.

Pulse Analysis

The rapid growth of transcatheter aortic valve replacement (TAVR) has pushed large centers like Sentara to seek tools that go beyond traditional cardiac CT. Static measurements, while reliable for routine cases, struggle to capture the nuanced interplay between a prosthetic frame, calcified leaflets, and patient‑specific anatomy. AI‑driven 3‑D platforms such as DASI address this gap by converting index CT scans into dynamic simulations that forecast how a valve will expand, deform, and interact with surrounding tissue, offering a more granular risk profile for each candidate.

At the core of DASI’s advantage is its ability to generate AI‑derived three‑dimensional narrowing assessments and a DLC/D ratio, which replace simple two‑dimensional distance checks. By virtually implanting various valve models, clinicians can visualize potential annular rupture, coronary occlusion, conduction disturbances, and post‑procedural gradients before entering the cath lab. This predictive capability is especially valuable for complex scenarios like valve‑in‑valve procedures, where leaflet‑sequestration and sinus obstruction pose heightened threats. The platform’s integration of 30‑day post‑implant data further refines its accuracy, turning each case into a learning loop that continuously improves future predictions.

The clinical impact is immediate and measurable. Sentara reports a more than 70 % reduction in BASILICA and other leaflet‑modification techniques, sparing patients from additional procedural risk while conserving resources. The ability to test multiple valve platforms and adjust implant depth enables truly individualized therapy, aligning device choice with patient anatomy and long‑term durability goals. As TAVR expands into younger, lower‑risk populations, such precision planning becomes a competitive differentiator, promising better outcomes, fewer complications, and stronger market positioning for hospitals that adopt advanced AI‑enabled imaging solutions.